Zacks: Analysts Expect Agilent Technologies Inc (A) Will Post Quarterly Sales of $1.16 Billion

Wall Street brokerages expect Agilent Technologies Inc (NYSE:A) to announce sales of $1.16 billion for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Agilent Technologies’ earnings. The lowest sales estimate is $1.15 billion and the highest is $1.17 billion. Agilent Technologies reported sales of $1.07 billion in the same quarter last year, which would suggest a positive year over year growth rate of 8.4%. The business is scheduled to announce its next earnings results after the market closes on Wednesday, February 14th.

According to Zacks, analysts expect that Agilent Technologies will report full-year sales of $1.16 billion for the current year, with estimates ranging from $4.74 billion to $4.79 billion. For the next year, analysts forecast that the business will report sales of $5.02 billion per share, with estimates ranging from $4.98 billion to $5.10 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Agilent Technologies.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The firm had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the prior year, the firm earned $0.59 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis.

A number of analysts have commented on A shares. Robert W. Baird reiterated a “buy” rating and issued a $70.00 price objective on shares of Agilent Technologies in a report on Friday, October 20th. ValuEngine downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Barclays increased their price objective on shares of Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Deutsche Bank set a $75.00 price objective on shares of Agilent Technologies and gave the company a “buy” rating in a report on Tuesday, November 21st. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a report on Tuesday, November 14th. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Agilent Technologies presently has an average rating of “Buy” and a consensus target price of $69.25.

Agilent Technologies (A) opened at $66.98 on Friday. The firm has a market cap of $21,635.75, a PE ratio of 31.90, a P/E/G ratio of 2.02 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. Agilent Technologies has a 1 year low of $50.02 and a 1 year high of $75.00.

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd were paid a $0.149 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date was Friday, December 29th. This represents a $0.60 annualized dividend and a dividend yield of 0.89%. Agilent Technologies’s dividend payout ratio is 28.57%.

In other news, insider Patrick Kaltenbach sold 7,358 shares of the stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $69.28, for a total value of $509,762.24. Following the completion of the sale, the insider now owns 72,862 shares of the company’s stock, valued at approximately $5,047,879.36. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Mark Doak sold 4,154 shares of the stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total transaction of $278,318.00. Following the completion of the sale, the vice president now directly owns 68,270 shares of the company’s stock, valued at approximately $4,574,090. The disclosure for this sale can be found here. In the last three months, insiders sold 219,991 shares of company stock valued at $15,468,795.

Several institutional investors have recently bought and sold shares of A. Dupont Capital Management Corp purchased a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $101,000. Front Row Advisors LLC purchased a new position in shares of Agilent Technologies during the 4th quarter worth approximately $106,000. AMG National Trust Bank purchased a new position in shares of Agilent Technologies during the 4th quarter worth approximately $201,000. Steward Partners Investment Advisory LLC purchased a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $213,000. Finally, Cannell Peter B & Co. Inc. purchased a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $215,000.

COPYRIGHT VIOLATION WARNING: “Zacks: Analysts Expect Agilent Technologies Inc (A) Will Post Quarterly Sales of $1.16 Billion” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/11/zacks-analysts-expect-agilent-technologies-inc-a-will-post-quarterly-sales-of-1-16-billion.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Get a free copy of the Zacks research report on Agilent Technologies (A)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply